Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,241,710
+$2,039,287 QoQ
Shares Held
239,671
+19.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,241,710 | 239,671 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,202,423 | 201,132 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,197,943 | 167,121 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,219,358 | 207,849 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,877,388 | 193,989 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,777,728 | 186,550 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,659,401 | 178,292 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,122,551 | 163,228 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,167,141 | 153,002 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,729,854 | 145,205 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,956,995 | 135,714 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $6,067,892 | 349,533 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,273,781 | 349,533 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,221,016 | 349,533 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,502,931 | 340,241 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,890,597 | 337,205 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,518,301 | 341,283 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,997,263 | 515,238 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,399,913 | 538,585 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,823,857 | 543,576 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $23,125,932 | 764,241 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||